The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
The Autophagy–Lysosomal Pathway in Neurodegeneration: A TFEB Perspective
Open accessAbstract
The autophagy-lysosomal pathway (ALP) is involved in the degradation of long-lived proteins. Deficits in the ALP result in protein aggregation, the generation of toxic protein species, and accumulation of dysfunctional organelles, which are hallmarks of Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and prion disease. Decades of research have therefore focused on enhancing the ALP in neurodegenerative diseases. More recently, transcription factor EB (TFEB), a major regulator of autophagy and lysosomal biogenesis, has emerged as a leading factor in addressing disease pathology. We review the regulation of the ALP and TFEB and their impact on neurodegenerative diseases. We also offer our perspective on the complex role of autophagy and TFEB in disease pathogenesis and its therapeutic implications through the examination of prion disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TFE3 or TFEB upregulation or activation through pharmacological inhibition of mTORC1 can trigger clearance of excess α-synuclein and halt the progression of neurotoxicity17–22.”
From PDCD4 triggers α-synuclein accumulation and motor deficits via co-suppressing TFE3 and TFEB translation in a model of Parkinson’s disease (2024) · cites this paper as [20]
Experimental — accuracy not yet measuredIn the citing paper
“Molecular and histopathologic analyses of patient tissues demonstrate mislocalized or accumulated autophagy machinery, pathogenic mutations underlying familial neurodegenerative diseases disable known autophagy-related factors, and genetically ablating autophagy effectors produce neurodegeneration in cell and animal model systems [74–81], supporting a role for autophagy dysfunction in the devel”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
Self-citationThe Role of Atg Proteins in Autophagosome Formation
Mizushima, N., Yoshimori, T., & Ohsumi, Y. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154005 · Cited by 2,978
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L., Sideris, D. P., Fogel, A. I., & Youle, R. J. (2015) · Nature · doi:10.1038/nature14893 · Cited by 2,774
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 436
Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs
Gnanadhas, D. P., Dash, P. K., Sillman, B., Bade, A. N., Lin, Z., Palandri, D. L., Gautam, N., Alnouti, Y., Gelbard, H. A., McMillan, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90025 · Cited by 51
“All of these organelles show the capacity to store ARV nanoparticles (26, 55).”
BackgroundYe, H., Ojelade, S. A., Li-Kroeger, D., Zuo, Z., Wang, L., Li, Y., Gu, J. Y., Tepass, U., Rodal, A. A., Bellen, H. J., et al. (2020) · eLife · doi:10.7554/elife.51977 · Cited by 51
“We next examined well-established markers of lysosomal autophagy, which plays a critical role in nervous system homeostasis and neurodegeneration (Martini-Stoica et al., 2016; Menzies et al., 2015).”
BackgroundThe Autophagy-Lysosomal Pathways and Their Emerging Roles in Modulating Proteostasis in Tumors
Dong, Z., & Cui, H. (2018) · Cells · doi:10.3390/cells8010004 · Cited by 50
“The ALPs are major regulatory machineries in the degradation of long-lived proteins, deficits of which result in protein aggregation, the generation of toxic protein species, and accumulation of dysfunctional organelles, which are hallmarks of neurodegenerative diseases, systemic amyloidosis, prion disease, as well as…”
BackgroundCyclic Oligosaccharides as Active Drugs, an Updated Review
Matencio, A., Caldera, F., Cecone, C., López-Nicolás, M., & Trotta, F. (2020) · Pharmaceuticals · doi:10.3390/ph13100281 · Cited by 50
“On the other hand, the essential activity of the transcription factor EB (TFEB) could be activated pharmacologically using HPβ-CD, a master regulator of the autophagy–lysosomal pathway [71], to prevent the accumulation of synuclein aggregates [72] (Figure 2).”
BackgroundMeireles, A. M., Shen, K., Zoupi, L., Iyer, H., Bouchard, E. L., Williams, A., & Talbot, W. S. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.10.003 · Cited by 47
“Moreover, TFEB activation promotes clearing of intracellular debris in laboratory models of neurodegenerative diseases such as Huntington’s disease (Appelqvist et al., 2013; Martini-Stoica et al., 2016; Williams et al., 2008), but the roles of RagA and TFEB in other aspects of CNS development and disease remain unexpl…”
BackgroundMolecular Mechanisms of Lysosome and Nucleus Communication
Zhao, Q., Gao, S. M., & Wang, M. C. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.06.004 · Cited by 50
Zhou, Y., Zhou, X., Huang, X., Hong, T., Zhang, K., Qi, W., Guo, M., & Nie, S. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07166 · Cited by 48
A lysosomal regulatory circuit essential for the development and function of microglia
Iyer, H., Shen, K., Meireles, A. M., & Talbot, W. S. (2022) · Science Advances · doi:10.1126/sciadv.abp8321 · Cited by 49
“In recent years, there has been an increasing appreciation of the dysregulation of Tfeb in neurodegenerative diseases ( 21 – 25 ), which has led to attempts toward enhancing cellular clearance by overexpressing Tfeb to activate autophagy and lysosomal pathways in cell culture or animal models of…”
Yang, J., Zhang, W., Zhang, S., Iyaswamy, A., Sun, J., Wang, J., & Yang, C. (2023) · Aging and Disease · doi:10.14336/ad.2022.0927 · Cited by 49
“Notably, impairment of lysosomal biogenesis and autophagy has been reported to be associated with the progression of these NDs [4].”
BackgroundCIB2 regulates mTORC1 signaling and is essential for autophagy and visual function
Sethna, S., Scott, P. A., Giese, A. P. J., Duncan, T. E., Jian, X., Riazuddin, S. A., Randazzo, P. A., Redmond, T. M., Bernstein, S. L., Riazuddin, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24056-1 · Cited by 47
Zhang, L., Wang, X., Yu, W., Ying, J., Fang, P., Zheng, Q., Feng, X., Hu, J., Xiao, F., Chen, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836494 · Cited by 46
Bayati, A., & McPherson, P. S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107742 · Cited by 47
Xu, S., Yang, P., Qian, K., Li, Y., Guo, Q., Wang, P., Meng, R., Wu, J., Cao, J., Cheng, Y., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.09.017 · Cited by 48
Sun, Y., Zhang, T., Zhang, Y., Li, J., Jin, L., Sun, Y., Shi, N., Liu, K., & Sun, X. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2599-3 · Cited by 45
“TFEB promotes the autophagosomal-lysosomal fusion for protein clearance and prevents accumulation of autophagosomes [52, 53].”
BackgroundXu, J., Ao, Y., Huang, C., Song, X., Zhang, G., Cui, W., Wang, Y., Zhang, X., & Zhang, Z. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00361-4 · Cited by 43
siRNA drug delivery across the blood–brain barrier in Alzheimer's disease
Sajid, M. I., Sheikh, F. S., Anis, F., Nasim, N., Sumbria, R. K., Nauli, S. M., & Tiwari, R. K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114968 · Cited by 50
Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
Wang, H., Zhou, R., Xu, F., Yang, K., Zheng, L., Zhao, P., Shi, G., Dai, L., Xu, C., Yu, L., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00385-8 · Cited by 48
“In particular, ubiquitin proteasomes degrade shortlived and soluble misfolded proteins [5], while lysosomes degrade long-lived proteins, insoluble protein aggregates, and intracellular parasites [6, 7].”
BackgroundLysosome-targeted fluorescent probes: Design mechanism and biological applications
Duan, X., Tong, Q., Fu, C., & Chen, L. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106832 · Cited by 43
Chamoli, M., Rane, A., Foulger, A., Chinta, S. J., Shahmirzadi, A. A., Kumsta, C., Nambiar, D. K., Hall, D., Holcom, A., Angeli, S., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00524-9 · Cited by 45
“14,15).”
Song, H., Chen, Y., Chen, Y., Park, J., Zheng, M., Surh, Y., Kim, U., Park, J. W., Yu, R., Chung, H., et al. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1791843 · Cited by 44
“in many neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s disease (PD) [4].”
BackgroundTao, J., Yang, P., Xie, L.-Q., Pu, Y., Guo, J., Jiao, J., Sun, L., & Lü, D. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16600 · Cited by 43
Srikanth, M. P., Jones, J. W., Kane, M. A., Awad, O., Park, T. S., Zambidis, E. T., & Feldman, R. A. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0386 · Cited by 44
“Deregulation of the ALP has been associated with promoting neurodegeneration in many neurodegenerative disorders including Alzheimer's disease, PD, and Huntington's disease.(58,59) This is primarily due to the role of the ALP in recycling of intracellular macromolecules, and the degradation of misfolded proteins and o…”
BackgroundMiT Family Transcriptional Factors in Immune Cell Functions
Kim, S., Song, H.-S., Yu, J., & Kim, Y. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0067 · Cited by 43
Qin, C., Bai, L., Li, Y., & Wang, K. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02765-8 · Cited by 44
Sirtuins and cognition: implications for learning and memory in neurological disorders
Fagerli, E. A., Escobar, I., Ferrier, F. J., Jackson, C. W., Lao, E. J. P., & Pérez‐Pinzón, M. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.908689 · Cited by 43
The cellular and pathologic prion protein
Gill, A. C., & Castle, A. R. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00002-7 · Cited by 45
Age-related endolysosome dysfunction in the rat urothelium
Truschel, S. T., Clayton, D. R., Beckel, J. M., Yabes, J. G., Yao, Y., Wolf‐Johnston, A., Birder, L. A., & Apodaca, G. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198817 · Cited by 46
The Molecular Clock and Neurodegenerative Disease: A Stressful Time
Carter, B., Justin, H. S., Gulick, D., & Gamsby, J. J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.644747 · Cited by 42
“An additional PTM that is characterized by the acetylation of CLOCK and BMAL1 mediates gene expression by interacting with histone acetyltransferases (HATs) (Masri and Sassone-Corsi, 2010; Zhang and Sehgal, 2019).”
BackgroundAge-Related Lysosomal Dysfunctions
Guerrero‐Navarro, L., Jansen‐Dürr, P., & Cavinato, M. S. (2022) · Cells · doi:10.3390/cells11121977 · Cited by 44
“TFEB also enhances the transcription of PGC1-α, which is the master regulator of mitochondrial biogenesis and participates in mitochondrial clearance [30].”
BackgroundAn update on the bridging factors connecting autophagy and Nrf2 antioxidant pathway
Ning, B., Hang, S., Zhang, W., Mao, C., & Li, D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1232241 · Cited by 43
“, 2015), longlived protein aggregates (Martini-Stoica et al., 2016), and lipid droplets (Settembre et al.”
BackgroundBrattås, P. L., Hersbach, B. A., Madsen, S., Petri, R., Jakobsson, J., & Pircs, K. (2020) · Autophagy · doi:10.1080/15548627.2020.1760014 · Cited by 40
“In line with this, inefficient activation of TFEB has been suggested to potentially worsen neurodegenerative diseases by increasing the aggregate formation [35].”
BackgroundPresenilin 1 phosphorylation regulates amyloid-β degradation by microglia
Ledo, J. H., Liebmann, T., Zhang, R., Chang, J. C., Azevedo, E. P., Wong, E., Silva, H. M., Troyanskaya, O. G., Bustos, V., & Greengard, P. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0856-8 · Cited by 41
Butler, V. J., Gao, F., Corrales, C. I., Cortopassi, W. A., Caballero, B., Vohra, M., Ashrafi, K., Cuervo, A. M., Jacobson, M. P., Coppola, G., et al. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008295 · Cited by 39
Xu, J., Zhang, X., & Zhang, Z. (2020) · Chinese Medicine · doi:10.1186/s13020-020-00402-1 · Cited by 39
Hao, Y., Su, C., Liu, X., Sui, H., Shi, Y., & Zhao, L. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212770 · Cited by 39
Wang, X., Zhu, Y., Zhu, Y., Sun, Y.-L., Huang, J., Li, Z., Wang, Y., Wu, J., Qin, Z., & Lin, F. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00720-6 · Cited by 40
“It is reported that deficiency in the autophagy-lysosomal pathway exhibits some neurodegeneration, including AD [32, 33].”
BackgroundErythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy
Yi, X., Yan, W., Guo, T., Liu, N., Wang, Z., Shang, J., Wei, X., Cui, X. Y., Sun, Y., Ren, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.883057 · Cited by 38
“The process of autophagy, which depends on lysosomes, is dedicated to specifically remove harmful or excessive cellular components such as protein aggregates or damaged organelles in cells (Martini-Stoica et al., 2016).”
BackgroundTargeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer
Lin, J., Liu, H., Wu, Y., Jin, J., Zhou, Y., Zhang, H., Nagle, D. G., Chen, H., Zhang, W., & Luan, X. (2023) · Small · doi:10.1002/smll.202207778 · Cited by 38
Autophagy-related proteins: Potential diagnostic and prognostic biomarkers of aging-related diseases
Miceli, C., Leri, M., Stefani, M., & Bucciantini, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101967 · Cited by 39
Methamphetamine-induced toxicity: The role of autophagy?
Roohbakhsh, A., Shirani, K., & Karimi, G. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.10.012 · Cited by 38
“Two complexes construct the autophagosomes: first, a complex of Atg6 (Beclin 1), class III PI3K plus Atg14 and the second is constructed by Atg12, Atg16, Atg5, and Atg7 [40].”
BackgroundEmerging genetic complexity and rare genetic variants in neurodegenerative brain diseases
Perrone, F., Cacace, R., van der Zee, J., & Broeckhoven, C. V. (2021) · Genome Medicine · doi:10.1186/s13073-021-00878-y · Cited by 38
“Deficits in this pathway result in protein aggregation and generating toxic protein species and accumulation of dysfunctional organelles [57].”
BackgroundWolframin is a novel regulator of tau pathology and neurodegeneration
Chen, S., Acosta, D. M., Li, L., Liang, J., Chang, Y., Wang, C., Fitzgerald, J., Morrison, C. T., Goulbourne, C. N., Nakano, Y., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02417-4 · Cited by 40
“TFEB, a master regulator of ALP [63, 65], has been widely demonstrated to ameliorate pathology in these diseases [4, 10, 47, 50].”
BackgroundDeregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson’s disease
Mubariz, F., Saadin, A., Lingenfelter, N., Sarkar, C., Banerjee, A., Lipinski, M. M., & Awad, O. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1152503 · Cited by 37
“Furthermore, pharmacological or genetic inhibition of mTOR activity is shown to improve autophagic clearance, reverse DA neuronal damage and alleviate PD symptoms (Jahrling and Laberge, 2015; Martini-Stoica et al., 2016).”
BackgroundMartino, R. M. C. D., Bisi, A., Rampa, A., Gobbi, S., & Belluti, F. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1339793 · Cited by 39
Tan, M., Jiang, B., Wang, H., Ouyang, W., Chen, X., Wang, T., Dong, D. F., Yi, S., Yi, J., Huang, Y., et al. (2019) · Journal of Cancer · doi:10.7150/jca.32807 · Cited by 37
“Accumulated evidence has led to the integrating hypothesis that activation of TFEB transactivates genes necessary for autophagosome formation, autophagosome-lysosome fusion, and cargo degradation [10].”
BackgroundDurairajan, S. S. K., Selvarasu, K., Bera, M. R., Rajaram, K., Iyaswamy, A., & Li, M. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210906125318 · Cited by 36
Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues
Chen, W., Wang, Q., Tao, H., Lu, L., Zhou, J., Wang, Q., Huang, W., & Yang, X. H. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024017 · Cited by 35
“In addition, the ROS/endoplasmic reticulum and ROS/TFEB pathways regulate osteoclast production and differentiation to a certain extent by affecting autophagy [128,129].”
BackgroundAugmenting autophagy for prognosis based intervention of COPD-pathophysiology
Bodas, M., & Vij, N. (2017) · Respiratory Research · doi:10.1186/s12931-017-0560-7 · Cited by 35
Deal, S. L., & Yamamoto, S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00700 · Cited by 36
Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases
Aman, Y., Ryan, B. J., Torsetnes, S. B., Knapskog, A., Watne, L. O., McEwan, W. A., & Fang, E. F. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.008 · Cited by 36
NDST3 deacetylates α‐tubulin and suppresses V‐ATPase assembly and lysosomal acidification
Tang, Q., Liu, M., Liu, Y., Hwang, R., Zhang, T., & Wang, J. (2021) · The EMBO Journal · doi:10.15252/embj.2020107204 · Cited by 32
“In particular, dysregulation of the autophagy-lysosomal pathway and associated proteostatic imbalance is a hallmark of neurodegenerative diseases (Martini-Stoica et al , 2016; Kurtishi et al , 2019).”
Khundadze, M., Ribaudo, F., Hussain, A., Rosentreter, J., Nietzsche, S., Thelen, M., Winter, D., Hoffmann, B., Afzal, M. A., Hermann, T., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.026 · Cited by 34
Genistein Activates Transcription Factor EB and Corrects Niemann–Pick C Phenotype
Argüello, G., Balboa, E., Tapía, P., Castro, J., Yañez, M. J., Mattar, P., Pulgar, R., & Zanlungo, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084220 · Cited by 33
“Within the contexts of different cellular and mouse disease models, where autophagic/ lysosomal substrates accumulate, several studies have shown that the induction of lysosomal biogenesis and autophagy through viral-mediated overexpression of TFEB can lead to the intracellular clearance of accumulating substrates as…”
BackgroundBest, H. L., Neverman, N. J., Wicky, H. E., Mitchell, N. L., Leitch, B., & Hughes, S. M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.01.001 · Cited by 35
Yuan, J., Zhang, N., Yin, L., Zhu, H., Zhang, L., Zhou, L., & Yang, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-18165-5 · Cited by 32
Khuansuwan, S., Barnhill, L. M., Cheng, S., & Bronstein, J. M. (2019) · Autophagy · doi:10.1080/15548627.2019.1580511 · Cited by 33
Abokyi, S., Shan, S. W., To, C. H., Chan, H. H., & Tse, D. Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5296341 · Cited by 32
“Based on the emerging role of autophagy in neurodegeneration, the inducers of transcription factor EB (TFEB), a major regulator of autophagy and lysosomal biogenesis, have received considerable attention [17, 18].”
Background20-Deoxyingenol alleviates osteoarthritis by activating TFEB in chondrocytes
Gu, M., Jin, J., Ren, C., Chen, X., Pan, Z., Wu, Y., Tian, N., Sun, L., Wu, A., Gao, W., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105361 · Cited by 33
Melatonin as a promising modulator of aging related neurodegenerative disorders: Role of microRNAs
Fathalizadeh, A., Rahnemayan, S., Rajabi, H., Vahed, N., Kashani, H. R. K., Rezabakhsh, A., & Sanaie, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105839 · Cited by 33
Yang, D.-S., Stavrides, P. H., Kumar, A. R., Jiang, Y., Mohan, P. S., Ohno, M., Dobrenis, K., Davidson, C. D., Saito, M., Pawlik, M., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx001 · Cited by 33
“To obtain insights into the underlying mechanism(s) for the increases in cathepsin levels and activity, we first examined if CYCLO induced alterations of TFEB and TFE3, members of the MiT family of transcription factors that drive the expression of most lysosomal genes, including cathepsins, as well as a number of oth…”
BackgroundLin, W., Zhao, L., Liang, G., Zhou, R., Zheng, X., Tao, R., Huo, Q., Su, C.-F., Li, M., Xu, N., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02698-w · Cited by 32
Zhou, X., Lai, Y.-H., Zhang, J., Li, Y., Wu, X., Yang, Y., Zhang, X., Ma, L., Zheng, K.-M., Liu, Y., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06540-w · Cited by 32
“Therefore, we sought to investigate whether the inhibitory effects of AOPPs on autophagy and lysosomal biogenesis in the present study were also mediated by ROS.”
Fu, X., Liu, Y., Zhang, H., Yu, X., Wang, X., Wu, C., & Yang, J. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113598 · Cited by 31
Gao, L., Dai, Y., Li, X., Meng, S., Zhong, Z., & Xu, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9843 · Cited by 31
“Defects of the ALP are strongly associated with AD and the ALP has been reported to regulate APP turnover and Aβ metabolism (43).”
BackgroundMolecular mechanisms of programmed cell death in methamphetamine-induced neuronal damage
Guo, D., Huang, X., Xiong, T., Wang, X., Zhang, J., Wang, Y., & Liang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.980340 · Cited by 31
Yan, H., Feng, L., & Li, M. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s380612 · Cited by 32
“150–152 Yang et al 153 demonstrated that celastrol, a new TFEB activator, facilitates the translocation of TFEB from the cytoplasm to the nucleus.”
BackgroundMingxin, H., Yu, Y., Tang, X., Dong, R., Li, X., Li, F., Jin, Y., Gong, S., Wang, X., Zeng, Z., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115632 · Cited by 30
Das, S., Murumulla, L., Ghosh, P., & Challa, S. (2025) · BioMetals · doi:10.1007/s10534-025-00665-x · Cited by 30
“This mechanism highlights the interplay between oxidative stress and lysosomal function, underscoring the critical role of MCOLN1 in regulating TFEB activity and maintaining cellular homeostasis through enhanced lysosomal and autophagic responses (Martini-Stoica et al. 2016).”
Trivedi, P. C., Bartlett, J. J., Mercer, A., Slade, L., Surette, M. E., Ballabio, A., Flibotte, S., Hussein, B., Rodrigues, B. B., Kienesberger, P. C., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165832 · Cited by 31
Self-citationZhou, X., Chen, X., Cheng, X., Lin, L., Quan, S., Li, S., Zhan, R., Wu, Q., & Liu, S. (2023) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2023.04.007 · Cited by 30
Enhancing TFEB-Mediated Cellular Degradation Pathways by the mTORC1 Inhibitor Quercetin
Huang, Y., Chen, Y., Shaw, A., Goldfine, H., Tian, J., & Cai, J.-Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5073420 · Cited by 28
“TFEB has been considered a therapeutic target with implications in various human diseases that are associated with defects in autophagy and lysosome-mediated degradation [1, 11].”
Pan, B., Lewno, M. T., Wu, P., & Wang, X. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00758 · Cited by 28
“…HF and essential for HF genesis as well (Wang et al., 2001a,b, 2011; Sanbe et al., 2004, 2007, 2009; Rajasekaran et al., 2007; Tannous et al., 2008b; McLendon and Robbins, 2011; Li et al., 2011a,b, 2017; Bhuiyan et al., 2013; Rajagopalan et al., 2013; Willis and Patterson, 2013; Meijering et …”
BackgroundWang, Y., Wu, Q., Anand, B. G., Karthivashan, G., Phukan, G., Yang, J., Thinakaran, G., Westaway, D. A., & Kar, S. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12647 · Cited by 29
Zhu, M., Zhang, S., Tian, X., & Wu, C. (2017) · Autophagy · doi:10.1080/15548627.2017.1362524 · Cited by 29
“Recently, research has emerged showing TFEB as a potent regulator of the autophagy-lysosomal pathway,(51,52) whose activation can promote lysosomal function and mitigate disease in a range of neurodegenerative disorders.(53) Here we show that”
BackgroundAutophagy-lysosomal defect in human CADASIL vascular smooth muscle cells
Hanemaaijer, E. S., Panahi, M., Swaddiwudhipong, N., Tikka, S., Winblad, B. G., Viitanen, M. H., Piras, A., & Behbahani, H. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.10.001 · Cited by 30
“Deficits in the autophagy-lysosomal pathway result in protein aggregation, generation of toxic protein species, and accumulation of dysfunctional organelles, which are hallmarks of many neurodegenerative disorders (Ciechanover and Kwon, 2015; Martini-Stoica et al., 2016; Zhang et al., 2009).”
BackgroundLysosomes and signaling pathways for maintenance of quiescence in adult neural stem cells
Kobayashi, T., & Kageyama, R. (2021) · The FEBS Journal · doi:10.1111/febs.15555 · Cited by 28
Kim, J. H., Yu, D.-H., Kim, H., Huh, Y. H., Cho, S., Lee, J.-K., Kim, H., & Kim, H. R. (2017) · Toxicology and Industrial Health · doi:10.1177/0748233717740066 · Cited by 28
The role S‐nitrosylation in manganese‐induced autophagy dysregulation in SH‐SY5Y cells
Ma, Z., Wang, C., Liu, C., Yan, D., Deng, Y. L., Liu, W., Yang, T., Xu, Z., & Xu, B. (2017) · Environmental Toxicology · doi:10.1002/tox.22457 · Cited by 27
“The autophagy-lysosomal pathway is the major degradation pathway by which longer-lived macromolecules and dysfunctional organelles are cleared.(7) Macroautophagy is the most common autophagic process,”
BackgroundÇelik, H., Karahan, H., & Kelicen‐Uğur, P. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13208 · Cited by 28
“[19–21] Many studies have shown the potential of statins to prevent the onset and development of AD.”
BackgroundInfluentialMoon, S.-H., Kwon, Y., Huh, Y. E., & Choi, H. J. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01386-2 · Cited by 27
Matye, D. J., Gunewardena, S., Chen, J., Wang, H., Wang, Y., Hasan, M. N., Gu, L., Clayton, Y. D., Du, Y., Chen, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33465-9 · Cited by 27
Chu, H.-Y., Wang, W., Chen, X., Jiang, Y.-E., Cheng, R., Xiao, Q., Zhong, Z.-M., Zeng, M., Zhu, X., & Sun, C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.03.003 · Cited by 28
Sweeney, N., Kim, T. Y., Morrison, C. T., Li, L., Acosta, D. M., Liang, J., Datla, N. V., Fitzgerald, J. A., Huang, H., Liu, X., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02810-1 · Cited by 28
Cai, X., Cai, X., Xie, Q., Xiao, X., Li, T., Zhou, T., & Sun, H. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00917 · Cited by 27
PPARα serves as a new receptor of aspirin for neuroprotection
Patel, D. R., Roy, A., & Pahan, K. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24561 · Cited by 27
Autophagy and Redox Homeostasis in Parkinson’s: A Crucial Balancing Act
Jiménez-Moreno, N., & Lane, J. D. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8865611 · Cited by 26
“TFEB translocation is regulated primarily by phosphorylation [313, 315], via ERK2 (at S142), and via the autophagy inhibitor mTORC1 (at S211 and S142), to retain TFEB in the cytoplasm by binding to 14-3-3 proteins [314, 316, 317].”
BackgroundSu, Y., Mao, L., Wang, Q., Xu, X., Qin, P., Huang, H., Zhang, Y., Zhou, Y., & Yan, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1837278 · Cited by 26
“Numerous studies have suggested that TFEB is a promising therapeutic target for PD [52].”
BackgroundSuzuki, Y., Hayashi, K., Goto, F., Nomura, Y., Fujimoto, C., & Makishima, M. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02139-4 · Cited by 28
“Autophagy (macroauto-phagy) is a highly conserved eukaryotic cellular process that degrades intracellular macromolecules in lysosomes [34] and is particularly important in nondividing cells such as auditory hair cells [35] and neurons [32] because it maintains homeostasis and protects hearing.”
BackgroundCurrim, F., Singh, J., Shinde, A., Gohel, D., Roy, M., Singh, K., Shukla, S., Mane, M., Vasiyani, H., & Singh, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02243-3 · Cited by 26
Prakash, R., Fauzia, E., Siddiqui, A. J., Yadav, S., Kumari, N., Singhai, A., Khan, M. A., Janowski, M., Bhutia, S. K., & Raza, S. S. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10212-z · Cited by 25
Wu, X. G., Ren, Y., Wen, Y., Lu, S. S., Li, H., Yu, H., Li, W., & Zou, F. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.02.001 · Cited by 25
Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research
Yuan, M., Wang, Y., Huang, Z., Jing, F., Qiao, P., Zou, Q., Li, J., & Cai, Z. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220145 · Cited by 26
Catalase-deficient mice induce aging faster through lysosomal dysfunction
Dutta, R. K., Lee, J. N., Maharjan, Y., Park, C., Choe, S., Ho, Y., Kwon, H. M., & Park, R. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00969-2 · Cited by 29
“Hence TFEB, a major regulator of autophagy and lysosomal biogenesis, phosphorylates and trafficked to nucleus for clearance of damaged lysosomes [35].”
BackgroundLi, Y., Yang, P., Meng, R., Xu, S., Zhou, L., Qian, K., Wang, P., Cheng, Y., Sheng, D., Xu, M., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.10.009 · Cited by 26
“Additionally, the augment of the nuclear and total expression of TFEB, a critical regulator of lysosomal function and biogenesis, whose transcriptional activity is activated upon nuclear translocation 37 , explained the mechanism by which RT-NM/ (Rapa þ GP-17) achieved lysosome regulation (Fig.”
BackgroundEarly Mitochondrial Fragmentation and Dysfunction in a Drosophila Model for Alzheimer’s Disease
Wang, X., & Davis, R. L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02107-w · Cited by 27
PPARα Between Aspirin and Plaque Clearance
Chandra, S., Roy, A., Patel, D. R., & Pahan, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190586 · Cited by 23
“Lyso-somal adaptation under different physiological as well as pathological scenario is dependent on a regulatory gene network known as CLEAR (coordinated lysosomal expression and regulation), with the master regulator TFEB at its core [69, 70].”
TFEB Dependent Autophagy-Lysosomal Pathway: An Emerging Pharmacological Target in Sepsis
Liu, X., Zheng, X., Lu, Y., Chen, Q., Zheng, J., & Zhou, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.794298 · Cited by 24
“TFEB is a master transcriptional factor of the ALP (Martini-Stoica et al., 2016) and was initially identified as a master regulator of lysosomal biogenesis and degradation (Sardiello et al.”
BackgroundInfluentialMoon, J.-H., Lee, J., Lee, Y.-J., & Park, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8670 · Cited by 24
Song, X., Aw, J. T. M., Ma, F., Cheung, M. F., Leung, D., & Herrup, K. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.0845-21.2021 · Cited by 23
Modulation of Tau Pathology in Alzheimer’s Disease by Dietary Bioactive Compounds
Shi, H., & Zhao, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020831 · Cited by 26
“A variety of dietary bioactive compounds have been reported to significantly inhibit tau aggregation as well as promote tau depolymerization in vivo and in vitro [166–168].”
Background
Metadata
- Authors
- Martini-Stoica, H., Xu, Y., Ballabio, A., & Zheng, H.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Zheng, Hui
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 39
- Issue
- 4
- Pages
- 221-234
- ISSN
- 0166-2236 (ISSN-L)
- PMC
- PMC4928589
- OpenAlex
- W2293027573
- Cited by
- 436
- References
- 127
- Citations by year
- 2026: 38 · 2025: 41 · 2024: 46 · 2023: 65 · 2022: 48 · 2021: 53 · 2020: 43 · 2019: 34 · 2018: 27 · 2017: 31 · 2016: 10
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (RF1AG020670, F30AG050412, R01AG020670)
- National Institute of Neurological Disorders and Stroke (R01NS076117, RF1NS093652, R01NS078072, R01NS093652)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- autophagy-lysosome pathway, TFEB, neurodegenerative diseases, lysosomal biogenesis, protein aggregation, Alzheimer's disease, Parkinson's disease, Huntington's disease, prion disease, autophagy regulation, therapeutic target
- MeSH terms
- Animals, Autophagy, Brain, Humans, Lysosomes, Nerve Degeneration, Neurodegenerative Diseases, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review